2020
DOI: 10.1016/j.drudis.2019.12.012
|View full text |Cite|
|
Sign up to set email alerts
|

An industrial approach towards solid dosage development for first-in-human studies: Application of predictive science and lean principles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(7 citation statements)
references
References 71 publications
0
6
0
1
Order By: Relevance
“…In the pharmaceutical industry, solid dosage forms are most commonly prescribed and preferred by most medical practitioners, due to their accurate dosing, superior stability, and high precision [ 22 , 23 ]. For instance, the Therapeutic Goods Administration (TGA), Australia approved 59 solid dosage form products in October 2015 containing A. paniculata [ 24 ].…”
Section: Conventional Dosage Formsmentioning
confidence: 99%
“…In the pharmaceutical industry, solid dosage forms are most commonly prescribed and preferred by most medical practitioners, due to their accurate dosing, superior stability, and high precision [ 22 , 23 ]. For instance, the Therapeutic Goods Administration (TGA), Australia approved 59 solid dosage form products in October 2015 containing A. paniculata [ 24 ].…”
Section: Conventional Dosage Formsmentioning
confidence: 99%
“…17 Sin embargo, hasta el momento no existe una cura efectiva para la infección por SARS-CoV-2, aunque múltiples medicamentos antivirales, incluyendo remdesivir y lopinavir más ritonavir, se han utilizado en la práctica clínica, si bien la seguridad y eficacia de éstos aún no están claros y están bajo evaluación clínica. 26 En un estudio se analizaron características específicas de pacientes con mal pronóstico en donde se identificó disminución progresiva de linfocitos y un aumento progresivo de la interleucina 6. 17…”
Section: Wwwmedigraphicorgmxunclassified
“…Polymorphism of APIs is the ability of API molecules to feature differences in molecular conformation, overall packing, or a combination of both in crystal structures. , Simple polymorphic systems, in contrast to multicomponent system like salts and cocrystals, generally advocate a simpler development approach as typically required in early phase drug development where the pace of the project is higher . Apart from a polymorphic system of anhydrous compounds, hydrate forms of APIs are also a still viable alternative of solid forms in early phase drug development owing that incorporation of water into the crystal structure may result in better physicochemical properties such as stability, especially of interest for liquid formulations including suspensions that are typically used in preclinical studies.…”
Section: Introductionmentioning
confidence: 99%